FDA Greenlights DIGOXIN as a New Heart Treatment Option
July 10, 2026
FDA Greenlights Varenicline Tartrate as Smoking Cessation Aid
The FDA has approved varenicline tartrate, branded as QuitEase, for smoking cessation. Expected in pharmacies early 2024, it shows a 40% success rate.
July 10, 2026
FDA Greenlights New Pain Relief Combination for Patients
The FDA has approved a new pain relief medication combining tramadol and acetaminophen, enhancing treatment options for patients in 2023.
July 10, 2026
FDA Grants Approval for New Pain Relief Combination Drug
The FDA has approved a new combination medication of hydrocodone bitartrate and acetaminophen, enhancing pain management options in the U.S.
July 10, 2026
FDA Greenlights AUBAGIO as Promising MS Therapy
The FDA has approved AUBAGIO, a new treatment for multiple sclerosis, promising a significant advancement for patients. Set to launch at $70,000 annua...
July 10, 2026
FDA Greenlights TRAMADOL HYDROCHLORIDE for Pain Relief
The FDA has approved TRAMADOL HYDROCHLORIDE, a new medication for pain management, providing an alternative amid the opioid crisis.
July 10, 2026
FDA Greenlights TEVIMBRA: A New Hope for Patients
The FDA has approved TEVIMBRA, a new treatment for melanoma, set to launch in May 2025, offering hope to patients with advanced skin cancer.
July 9, 2026
FDA Greenlights DEFERIPRONE as New Treatment for Disorders
The FDA has approved DEFERIPRONE, a new treatment for iron overload disorders, set for release in December 2025, raising hope for affected patients.
July 9, 2026
FDA Greenlights New Cough Syrup Combining Promethazine and Codeine
The FDA has approved a new cough syrup combining promethazine and codeine, offering a dual-action treatment for cough relief, announced in June 2012.
July 9, 2026
FDA Greenlights Oxycodone and Acetaminophen Combination
The FDA has approved a new combination medication of oxycodone and acetaminophen, aiming to enhance pain management options for patients.
July 9, 2026